IgG4-related kidney disease: from renal histopathology and immunopathogenesis to novel pharmacological interventions
Speculating on a potential scenario that dominates IgG4-RD's treatment reality in 5 years, the advent of integrative treatment strategies combining both B- and T-cell targeting agents is conceivable.
Authors
- Eva Baier (ORCID: https://orcid.org/0000-0001-9055-1364)
- Augusto Vaglio
Institutions
- University Medical Center (US)
- Meyer Children's Hospital (IL)
- Meyer Children's Hospital (IT)
- University of Florence (IT)
- University of Göttingen (DE)
Publication Details
- Journal
- Expert Review of Clinical Immunology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1080/1744666x.2025.2575448
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00